from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2185c/TB16.3

LFCtreatmentdescriptionclass of inhibitor

1.549

Amikacinug/mL Amikacintranslation

2.124

Cap5-10ug/mL Capreomycintranslation

1.932

Rox10-50 ug/mL Roxithromycintranslation

0.422

SM2-5 ug/mL Streptomycintranslation

0.947

Tet5-10 ug/mL Tetracyclinetranslation

-1.700

Rif0.2-5ug/mL Rifampicintranscription

-0.364

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.761

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.489

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.351

CPZ10-50 ug/mL Chlorpromazinerespiration

0.416

Clofazimine10-13 ug/mL Clofaziminerespiration

0.486

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.622

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.761

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.080

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.342

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.423

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.042

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.836

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.304

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.584

KCN5-20 ug/mL Potassium cyaniderespiration

-0.599

NaN30.2-2 mM Sodium aziderespiration

0.858

Nigericin50 uM Nigericinrespiration

0.829

TRC10-150 ug/mL Triclosanrespiration

0.766

TRZ10-25 ug/mL Thioridazinerespiration

-0.835

Valinomycin0.5-10 uM Valinomycinrespiration

0.726

ZnSO42 mM ZnSO4respiration

0.308

menadione6-10 ug/mL Menadionerespiration

-0.299

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.148

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.001

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.347

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.404

NRP_1Non-replicating persistence stage 1dosRassociated

0.078

Amp0.2mg/mL AmpicillincellWall

-0.016

Cephalexin20-100 ug/mL CephalexincellWall

0.464

Cerulenin0.32-5 ug/mL CerulenincellWall

0.604

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.145

EMB10-20 ug/mL EthambutolcellWall

0.209

Eta12-40 ug/mL EthionamidecellWall

0.283

INH0.2-0.4 ug/mL IsoniazidcellWall

0.120

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.651

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.521

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.918

BZA0.12 mg/mL BenzamidearomaticAmides

0.014

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.892

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.144

H2O24 mM hydrogen peroxideDNAdamaging

-0.052

Levo10 ug/mL LevofloxacinDNAdamaging

0.110

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.021

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.203

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.462

UVUV-irradiationDNAdamaging

-0.771

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.010

Antimycin12.5-50 ug/mL Antimycin A?

0.148

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.040

PA_110-50 ug/mL Antitubercular compound PA-1?

0.227

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.438

PA8240.2-2 ug/mL PA-824?

-1.741

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.973

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.032

Verapamil50 uM Verapamil?

-0.226

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.313

methoxatin10-20 ug/mL Methoxatin?